Skip to main content
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.290
-0.250 (-7.06%)
At close: Dec 5, 2025, 4:00 PM EST
3.390
+0.100 (3.04%)
After-hours: Dec 5, 2025, 7:06 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2019 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '19 2018 - 2019
Antibody Drug Conjugate Cancer Therapies
70.84M
Log In
Log In
Log In
Log In
Upgrade
Antibody Drug Conjugate Cancer Therapies Growth
1.84%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2019 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '19 2018 - 2019
United States
69.28M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
0.32%
Log In
Log In
Log In
Log In
Upgrade
EMEA
1.56M
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
212.65%
Log In
Log In
Log In
Log In
Upgrade